Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
05/2003
05/08/2003WO2003037873A1 Substituted benzo[b]azepin-2-one compounds
05/08/2003WO2003037872A1 Therapeutic quinoline compounds with 5-ht-antagonistic properties
05/08/2003WO2003037871A1 Therapeutic quinolone compounds with 5-ht-antagonistic properties
05/08/2003WO2003037870A1 Substituted 1h-quinolin-2-one compounds
05/08/2003WO2003037869A1 Amide derivatives as glycogen synthase kinase 3-beta inhibitors
05/08/2003WO2003037863A2 Substituted indoles, method for production and use thereof for the inhibition of pain
05/08/2003WO2003037853A1 Substituted thioacetamides
05/08/2003WO2003037852A1 Allenic aryl sulfonamide hydroxamic acids as matrix metalloproteinase and tace inhibitors
05/08/2003WO2003037847A1 Benzamide derivatives as antagonists of orexin receptors
05/08/2003WO2003037384A2 Polymer conjugates of protein kinase c inhibitors
05/08/2003WO2003037362A2 Mnk kinase homologous proteins involved in the regulation of energy homeostasis and organelle metabolism
05/08/2003WO2003037361A2 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis
05/08/2003WO2003037358A1 A pharmaceutical composition having cholagogic and litholytic effect and its preparation method
05/08/2003WO2003037354A1 USE OF (11β, 17β)-11-(1,3-BENZODIOXOL-5-YL)-17-HYDROXY-17-(1-PROPYNYL)-ESTRA-4,9-DIEN-3-ONE IN THE TREATMENT OF MAJOR DEPRESSIVE DISORDER
05/08/2003WO2003037352A1 1-phenyl-5-n-heterocyclyl-pyrazoles as cyclooxygenase inhibitors for the treatment of inflammation associated disorders
05/08/2003WO2003037351A1 Heterocyclo-alkylsulfonyl pyrazoles and their use as cox-2 inhibitors
05/08/2003WO2003037350A1 New dry and aqueous epinastine-syrup-formulation
05/08/2003WO2003037349A1 Type 4 phosphodiesterase inhibitors and uses thereof
05/08/2003WO2003037342A1 Method of treating depression with delta receptor agonist compounds
05/08/2003WO2003037338A2 Modulators of the cholesterol biosynthetic pathway
05/08/2003WO2003037337A1 Depot formulations of iloperidone and a star polymer
05/08/2003WO2003037336A1 1-(5-sulfonyl-pyridin-2-yl)-5-(methylidene-cycloalkylmethoxy)-1h-pyrazole-4-carbonitrile derivatives and other compounds as cyclooxygenase inhibitors for the treatment of arthritis, neurodegeneration and colon cancer
05/08/2003WO2003037335A1 5-heteroatom-substituted pyrazoles
05/08/2003WO2003037333A1 Pyridine derivatives as nmda-receptor subtype blockers
05/08/2003WO2003037332A1 Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity
05/08/2003WO2003037330A1 Sulfonyl-and sulfonylheteroaryl-pyrazoles with a hydrazinyl or nitrogen oxide substituent at the 5-position for use as cyclooxygenase inhibitors
05/08/2003WO2003037329A1 Nicotinic acetylcholine receptor agonists in the treatment of restless legs syndrome
05/08/2003WO2003037325A1 Hydroxy substituted amides for the treatment of alzheimer's disease
05/08/2003WO2003037324A1 Use of an opuntia ficus-indica extract and compounds isolated therefrom for protecting nerve cells
05/08/2003WO2003037322A1 Combination of an atp-competitive inhibitor of bcr/abl kinase activity and a tyrphostin analog
05/08/2003WO2003037320A1 Pharmaco-dietary preparation having a nutrition-supplementing and nutrition-enhancing effect
05/08/2003WO2003037313A2 Methods for the treatment of addiction
05/08/2003WO2003037308A2 Utilization of inhibitors of rho-kinases for stimulating nerve growth, inhibiting scar tissue formation and/or reducing a secondary lesion
05/08/2003WO2003037303A1 Spray drying methods and compositions thereof
05/08/2003WO2003037260A2 Methods and compositions for treating parkinson's disease
05/08/2003WO2003037258A2 Methods and compositions for the treatment and diagnosis of pain disorders using 2047
05/08/2003WO2003037254A2 Methods and compositions for the treatment and diagnosis of pain disorders using 46566
05/08/2003WO2003037167A2 Pathway of rantes-mediated chemokine synthesis in astrocytes and methods of use therefor
05/08/2003WO2003037159A2 An albuterol and ipratropium inhalation solution, system, kit and method for relieving symptoms of chronic obstructive pulmonary disease
05/08/2003WO2003023404A8 A method of diagnosis and treatment and agents useful for same
05/08/2003WO2003014322A3 Proteins associated with cell growth, differentiation, and death
05/08/2003WO2003004000A3 Topical composition for treating pain
05/08/2003WO2003002595A3 Dipeptidyl peptidase iv inhibitors and their uses as anti-cancer agents
05/08/2003WO2002098482A3 System for osmotic delivery of pharmaceutically active agents
05/08/2003WO2002090974A3 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
05/08/2003WO2002090524A3 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
05/08/2003WO2002085414A3 Nsaid formulations comprising lecithin oils for protecting the gastrointestinal tract and providing enhanced therapeutic activity
05/08/2003WO2002085341A3 Composition, containing carnitine and huperzin for the preventionor treatment of learning disorders in children suffering from attention deficit/hyperactive disorder
05/08/2003WO2002081499A3 Somatostatin agonists
05/08/2003WO2002072608A3 POLYMERIC IMMUNOGLOBULIN FUSION PROTEINS THAT TARGET LOW-AFFINITY FCηRECEPTORS
05/08/2003WO2002060897A3 Process for making substituted 8-arylquinolinium benzenesulfonate
05/08/2003WO2002057226A3 68730 and 69112 protein kinase molecules and uses therefor
05/08/2003WO2002049630A3 Method for preventing or treating pain by administering an endothelin antagonist
05/08/2003WO2002048152A3 Spiro[isobenzofuran-1,4'-piperidin]-3-ones and 3h-spiroisobenzofuran-1,4'-piperidines
05/08/2003WO2002026946A3 Fad4, fad5, fad5-2, and fad6, fatty acid desaturase family members and uses thereof
05/08/2003WO2002026223A3 Catecholamine pharmaceutical compositions and methods
05/08/2003WO2002024715A3 Gamma-hydroxybutyrate compositions containing carbohydrate, lipid or amino acid carriers
05/08/2003WO2002010216A3 Proteins and nucleic acids encoding same
05/08/2003WO2001075454A3 Diagnosis and treatment of alzheimer's disease
05/08/2003US20030088236 Implantable devices and methods for treatment of pain by delivery of fentanyl and fentanyl congeners
05/08/2003US20030088199 Analgesic and anti-inflammatory patches for external use containing 4-biphenylylylacetic acid
05/08/2003US20030088111 Protected forms of pharmacologically active agents and uses therefor
05/08/2003US20030088094 Novel synthesis and crystallization of piperazine ring-containing compounds
05/08/2003US20030088085 MPROT12 polynucleotides and methods thereof
05/08/2003US20030087965 Including neuropathic pain.
05/08/2003US20030087963 Methods of preparing and using 2-hydroxy derivatives of sibutramine and its metabolites
05/08/2003US20030087956 Useful in the treatment of disease mediated by the interaction between VCAM-1 and/or fibronectin and the integrin receptor alpha 4 beta 1.
05/08/2003US20030087949 For treating neurodegenerative diseases, diseases of circulatory organs, hepatitis, renal diseases, inflammatory skin disorders, radiation disorders, viral diseases, prion diseases, etc.; preservatives
05/08/2003US20030087948 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use
05/08/2003US20030087938 Treatment of chronic pain with 3-heterocycloxy-and 3-cycloalkyloxy-3-phenylpropanamines
05/08/2003US20030087933 Use of central cannabinoid receptor antagonist for preparing medicines designed to facilitate smoking cessation
05/08/2003US20030087926 Substituted 1,2,3,4-tetrahydroquinoline-2-carboxylic acid derivatives
05/08/2003US20030087924 Diacid-substituted heteroaryl derivatives as matrix metalloproteinase inhibitors
05/08/2003US20030087922 Aryl substituted 2-aminopyrimidines and 2-aminopyridines
05/08/2003US20030087919 Rho-kinase inhibitors
05/08/2003US20030087917 Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system
05/08/2003US20030087916 Pyrimidin-4-one compounds
05/08/2003US20030087912 Aryl oxime-piperazines useful as CCR5 antagonists
05/08/2003US20030087911 Methods and compositions for treating hypertension
05/08/2003US20030087904 Xanthine derivatives, such as 3-isobutyl-8-pyrrolidinylxanthine; treating asthma, diarrhea, etc.
05/08/2003US20030087903 Mevinolin derivatives
05/08/2003US20030087902 Substituted indoles, pharmaceutical compounds containing such indoles and their use as PPAR-gamma binding agents
05/08/2003US20030087901 Compounds and methods for modulation of estrogen receptors
05/08/2003US20030087899 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound.
05/08/2003US20030087898 Opioid receptor antagonists; treating irritable bowel syndrome, drug addiction or dependency, depression, and eating disorders.
05/08/2003US20030087897 Containing carboxylic acid groups; diagnosis; prophylaxis
05/08/2003US20030087888 Anticancer agents
05/08/2003US20030087883 Therapeutic 5-HT ligand compounds
05/08/2003US20030087832 Anticancer agents; antidiabetic agents, anticholesterol agents, cardiovascular disorders, osteoporosis
05/08/2003US20030087817 Regulation of endogenous gene expression in cells using zinc finger proteins
05/08/2003US20030087816 Anticancer, antitumor agents; genetic engineering
05/08/2003US20030087801 Methods for treatment using novel ligands of the neuropeptide receptor hfgan72
05/08/2003US20030087412 Nucleotide sequences coding polypeptide for use in the prevention and treatment of tumors, nervous system, cardiomyopathy, viral and metabolic diseases
05/08/2003US20030087407 Peptides and pharmaceutical compositions thereof for treatment of disorders or diseases associated with abnormal protein folding into amyloid or amyloid-like deposits
05/08/2003US20030087378 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders
05/08/2003US20030087377 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of cancer, psoriasis and nervous system disorders
05/08/2003US20030087341 Nucleotide sequences coding polypeptide for use in the diagnosis, prevention and treatment of autoimmune disease
05/08/2003US20030087340 Novel human leucine-rich repeat containing protein expressed predominately in nervous system tissues, HLRRNS1
05/08/2003US20030087317 Human NIM1 kinase
05/08/2003US20030087307 Compound for use in the prevention and treatment of respiratory and nervous system disorders
1 ... 1217 1218 1219 1220 1221 1222 1223 1224 1225 1226 1227 1228 1229 1230 1231 1232 1233 1234 1235 1236 1237 ... 1833